Joint Health Care: Real-World Tactics to Address Health Inequities
Premiere Date: Monday, October 24, 2022This activity offers CE credit for:
%>- ABIM (MOC)
- ABA (MOC)
- ABS (CC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, October 24, 2025
Monica E. Peek, MD, MPH, MSc (Moderator) (she/her/hers) Ellen H. Block Professor of Health Justice in the Department of Medicine Associate Director, Chicago Center for Diabetes Translation Research Director of Research, MacLean Center for Clinical Medical Ethics The University of Chicago Chicago, IL |
Haydée C. Brown, MD (she/her/hers/ella) Attending Orthopaedic Surgeon NYC Health and Hospitals/Harlem Assistant Clinical Professor Department of Orthopaedic Surgery Mount Sinai Health System Founder & President Black Women Orthopaedic Surgeons (BWOS) New York, NY |
Disparities in joint health, including access to orthopedic care and rates of surgical intervention for disabling osteoarthritis, exist among racial and ethnic underserved and underrepresented populations. To establish equitable joint health care, it is critical not only to understand the role that race, bias, and social determinants of health education play but also to implement standardized screening, empathy, cultural sensitivity, and personalized care.
In this CME Outfitters BriefCase, Drs. Peek and Brown will guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that reduce the quality of joint health care for racial and ethnic underserved patients. This program will provide actionable strategies, empowering attendees to recognize factors that contribute to care inequities and implement changes in practice to improve access to tools and treatment for patients with joint health concerns.
At the end of this CE activity, participants should be able to:
- Identify the impact of health inequities on patients with joint health concerns.
- Individualize treatment strategies that include assessment of SDoH for optimal outcomes in patients with joint pain.
Supported by an educational grant from Johnson & Johnson.
Physicians, PAs, NPs, nurses, pharmacists, physical therapists, occupational therapists specializing in rheumatology, dermatology, orthopedics, surgery, pain, anesthesiology, or primary care.
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Dr. Peek reports the following financial relationships:
Consultant: Pfizer Inc.
Dr. Brown reports the following financial relationships:
Consultant: DePuy Synthes/Johnson & Johnson
Other Financial or Material Support: Founder and President, Black Women Orthopaedic Surgeons
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
BC-076-102422-57